✦ LIBER ✦

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

✍ Scribed by Raizer, Jeffrey J.; Grimm, Sean A.; Rademaker, Alfred; Chandler, James P.; Muro, Kenji; Helenowski, Irene; Rice, Laurie; McCarthy, Katie; Johnston, Sandra K.; Mrugala, Maciej M.; Chamberlain, Marc

Book ID: 121545991
Publisher: Springer US
Year: 2014
Tongue: English
Weight: 441 KB
Volume: 117
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-014-1358-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of the oral VEGF recept

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)

✍ Gupta, Pankaj; Mulkey, Flora; Hasserjian, Robert P.; Sanford, Ben L.; Vij, Ravi; 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 204 KB

3010 ORAL Final overall survival (OS) re

3010 ORAL Final overall survival (OS) results of CONFIRM 1 (CF1), a randomized, double-blind, placebo-controlled phase III trial in patients with metastatic adenocarcinoma of the colon or rectum (mCRC) receiving first line chemotherapy with oxaliplatin/5-fluorouracil/Leucovorin (FOLFOX 4) and PTK787/ZK 222584 (PTK/ZK) or placebo (PBO)

✍ J.R. Hecht; T. Trarbach; E. Jaeger; J. Hainsworth; R.A. Wolff; K. Lloyd; G. Bodo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A phase II trial of thalidomide and proc

A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas

✍ Jimmy Ruiz; Doug Case; Gina Enevold; Robin Rosdhal; Stephen B. Tatter; Thomas L. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 205 KB

35 POSTER A Phase I trial of a combinati

35 POSTER A Phase I trial of a combination of the mToR Inhibitor Everolimus (RAD001) and two schedules of the vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor Vatalanib (PTK787/ZK222584) in patients (pts) with advanced solid tumors

✍ G. Dy; G. Croghan; A. Furth; J. Reid; L. Hanson; M. Roos; A. Tan; A. Adjei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

A Phase II trial of paclitaxel and topot

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

✍ J. Marc Pipas; Louise P. Meyer; C. Harker Rhodes; Laurence D. Cromwell; Carol E. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 286 KB

A phase II trial of a multi-agent oral a

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

✍ Robison, Nathan J.; Campigotto, Federico; Chi, Susan N.; Manley, Peter E.; Turne 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB